Veracyte (VCYT) EBIAT: 2012-2025
Historic EBIAT for Veracyte (VCYT) over the last 13 years, with Sep 2025 value amounting to $19.1 million.
- Veracyte's EBIAT rose 26.28% to $19.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.3 million, marking a year-over-year increase of 427.11%. This contributed to the annual value of $24.1 million for FY2024, which is 132.44% up from last year.
- Per Veracyte's latest filing, its EBIAT stood at $19.1 million for Q3 2025, which was up 2,052.76% from -$980,000 recorded in Q2 2025.
- Over the past 5 years, Veracyte's EBIAT peaked at $19.1 million during Q3 2025, and registered a low of -$41.9 million during Q1 2021.
- Moreover, its 3-year median value for EBIAT was -$980,000 (2025), whereas its average is -$2.3 million.
- As far as peak fluctuations go, Veracyte's EBIAT tumbled by 636.03% in 2023, and later skyrocketed by 478.06% in 2025.
- Over the past 5 years, Veracyte's EBIAT (Quarterly) stood at -$10.5 million in 2021, then spiked by 63.49% to -$3.8 million in 2022, then crashed by 636.03% to -$28.3 million in 2023, then spiked by 118.07% to $5.1 million in 2024, then rose by 26.28% to $19.1 million in 2025.
- Its EBIAT was $19.1 million in Q3 2025, compared to -$980,000 in Q2 2025 and $7.0 million in Q1 2025.